You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2024

Details for Patent: 10,857,161


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,857,161 protect, and when does it expire?

Patent 10,857,161 protects AGAMREE and is included in one NDA.

This patent has forty-four patent family members in twenty-one countries.

Summary for Patent: 10,857,161
Title:Non-hormonal steroid modulators of NF-kB for treatment of disease
Abstract:Provided herein is a pharmaceutical composition comprising a compound having the structural formula
Inventor(s):McCall John M., Hoffman Eric, Nagaraju Kanneboyina
Assignee:ReveraGen BioPharma, Inc.
Application Number:US16226061
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,857,161: A Comprehensive Guide

Introduction

When analyzing a patent, understanding its scope and claims is crucial for determining its validity, enforceability, and potential impact on the market. This article will delve into the details of United States Patent 10,857,161, providing a thorough analysis of its scope, claims, and the broader patent landscape.

Understanding the Patent System

Before diving into the specifics of the patent, it's essential to understand the broader context of the patent system. The U.S. Patent and Trademark Office (USPTO) is responsible for granting U.S. patents and registering trademarks. Patents are granted for inventions that are novel, non-obvious, and useful[2].

Patent 10,857,161 Overview

Patent Title and Abstract

To begin, one must identify the title and abstract of the patent. While the specific details of Patent 10,857,161 are not provided here, typically, the title gives a brief description of the invention, and the abstract provides a concise summary of the disclosure.

Claims

The claims section is the most critical part of a patent as it defines the scope of the invention. Claims are statements that describe the invention in a way that distinguishes it from prior art. There are two main types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention without reference to other claims, while dependent claims refer back to an independent claim and further limit the invention[3].

Analyzing the Claims of Patent 10,857,161

Independent Claims

Independent claims are the foundation of the patent and define the broadest scope of the invention. For example, if Patent 10,857,161 is related to a pharmaceutical drug, an independent claim might describe the composition of the drug, its method of use, or its unique characteristics.

Dependent Claims

Dependent claims narrow down the scope of the invention by adding additional limitations. These claims are often used to protect specific embodiments or variations of the invention. For instance, a dependent claim might specify a particular dosage form or a specific method of administration.

Scope of the Patent

Patent Scope Measurements

The scope of a patent can be measured using various metrics, such as the number of claims, the breadth of the claims, and the dependency between claims. The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents, including claim-level statistics and document-level statistics, which can help in assessing the scope of a patent[3].

Prior Art and Citations

Understanding the prior art cited in the patent is crucial for determining its novelty and non-obviousness. The Common Citation Document (CCD) application consolidates prior art citations from multiple patent offices, providing a comprehensive view of the prior art landscape[1].

Patent Landscape Analysis

Global Patent Family

To understand the global reach of the patent, one must analyze the patent family. The Global Dossier service provided by the USPTO allows users to see all related applications filed at participating IP offices, along with their dossier, classification, and citation data[1].

International Patent Offices

Searching international patent databases, such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), can reveal if similar inventions have been patented abroad. This is essential for assessing the global competitiveness and potential infringement risks[1].

Economic and Market Impact

Patent-Based Citation Analysis

Patent-based citation analysis can provide insights into the technological development and market impact of the patent. By tracing backward citations, one can understand the influence of past inventive activities on the current patent. This method has been used to study the development of technologies like nanotechnology[4].

Market Dominance

A patent with broad claims and a strong prior art foundation can significantly impact the market by preventing others from making, using, or selling the invention. This can lead to market dominance, especially if the patent covers a critical component or process in its field.

Legal and Regulatory Considerations

Office Actions and Examinations

The Patent Examination Data System (PEDS) provides access to bibliographic data for all publicly available patent applications. Analyzing office actions and examination reports can give insights into the patent's validity and any potential legal challenges it may face[1].

Patent Assignments and Ownership

Changes in patent ownership can affect its enforcement and licensing. The Patent Assignment Search tool allows users to search for patent assignments and changes in ownership, which is crucial for understanding the current legal status of the patent[1].

Conclusion

Analyzing the scope and claims of United States Patent 10,857,161 involves a detailed examination of its claims, prior art, and global patent landscape. Here are the key takeaways:

  • Claims Analysis: Understanding independent and dependent claims is crucial for defining the scope of the invention.
  • Prior Art: Analyzing prior art citations helps in determining the novelty and non-obviousness of the patent.
  • Global Patent Family: Using services like Global Dossier to see related applications filed at participating IP offices.
  • International Patent Offices: Searching international databases to assess global competitiveness.
  • Economic and Market Impact: Patent-based citation analysis can reveal technological development and market impact.
  • Legal and Regulatory Considerations: Analyzing office actions, examination reports, and patent assignments is essential for understanding the patent's legal status.

FAQs

Q: How do I search for existing patents related to my invention?

A: You can use the USPTO's Patent Public Search tool or visit the USPTO Public Search Facility to access patent and trademark information. Additionally, you can search international patent databases through services like the EPO's esp@cenet and WIPO's PATENTSCOPE[1].

Q: What is the significance of independent and dependent claims in a patent?

A: Independent claims define the broadest scope of the invention, while dependent claims narrow down the scope by adding additional limitations. This helps in protecting specific embodiments or variations of the invention[3].

Q: How can I determine the global reach of a patent?

A: Use the Global Dossier service to see all related applications filed at participating IP offices, along with their dossier, classification, and citation data[1].

Q: What is the role of prior art in patent analysis?

A: Prior art citations help in determining the novelty and non-obviousness of the patent. The Common Citation Document (CCD) application consolidates prior art citations from multiple patent offices[1].

Q: How can patent-based citation analysis impact market strategy?

A: Patent-based citation analysis can provide insights into technological development and market impact by tracing backward citations, helping in understanding the influence of past inventive activities on the current patent[4].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. OECD - Capturing Nanotechnology's Current State of Development via Patent Analysis: https://www.oecd-ilibrary.org/docserver/168778071481.pdf?expires=1730924680&id=id&accname=guest&checksum=884C0E33042F069EFF4F8C477CCB2720

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,857,161

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Catalyst Pharms AGAMREE vamorolone SUSPENSION;ORAL 215239-001 Oct 26, 2023 RX Yes Yes 10,857,161 ⤷  Subscribe Y TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,857,161

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2805720 ⤷  Subscribe 301273 Netherlands ⤷  Subscribe
European Patent Office 2805720 ⤷  Subscribe CA 2024 00018 Denmark ⤷  Subscribe
Australia 2009260471 ⤷  Subscribe
Brazil PI0909564 ⤷  Subscribe
Canada 2725008 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.